{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T14:19:27Z","timestamp":1794665967393,"version":"4.9.1"},"reference-count":32,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2009,12,18]],"date-time":"2009-12-18T00:00:00Z","timestamp":1261094400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[2010,7]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>\n                    <jats:bold>Objective\u2002<\/jats:bold>\n                    To describe mortality and disease\u2010specific morbidities in patients with mild primary hyperparathyroidism (PHPT).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Design\u2002<\/jats:bold>\n                    Retrospective population\u2010based observational study.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Setting\u2002<\/jats:bold>\n                    Tayside, Scotland, from 1997 to 2006.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Participants\u2002<\/jats:bold>\n                    Patients with mild PHPT were selected from a predefined PHPT cohort between 1997 and 2006.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Main outcome measures\u2002<\/jats:bold>\n                    Standardised mortality ratios (SMRs) were examined for all\u2010cause mortality, as well as cardiovascular and cancer mortality. Standardised morbidity ratios and standardised incidence ratios were also calculated for eleven observed co\u2010morbidities.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results\u2002<\/jats:bold>\n                    In total, there were 1683 (69\u00b71% female) patients identified with mild PHPT in Tayside. Patients were found to have an increased risk of all\u2010cause mortality and cardiovascular mortality (SMR\u2010all cause 2\u00b762, 95% CI 2\u00b739\u20132\u00b786; SMR\u2010cardiovascular 2\u00b768, 95% CI 2\u00b734\u20133\u00b705). Patients with mild PHPT had a significantly increased risk of developing cardiovascular and cerebrovascular disease, renal dysfunction and fractures compared to the age\u2010 and sex\u2010adjusted general population.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusions\u2002<\/jats:bold>\n                    Mortality and morbidity were increased for patients with mild untreated PHPT, which is similar to more severe PHPT.\n                  <\/jats:p>","DOI":"10.1111\/j.1365-2265.2009.03766.x","type":"journal-article","created":{"date-parts":[[2009,12,18]],"date-time":"2009-12-18T09:45:37Z","timestamp":1261129537000},"page":"30-34","source":"Crossref","is-referenced-by-count":169,"title":["Increased mortality and morbidity in mild primary hyperparathyroid patients. The Parathyroid Epidemiology and Audit Research Study (PEARS)"],"prefix":"10.1111","volume":"73","author":[{"given":"Ning","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter T.","family":"Donnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W. V.","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Rudman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham P.","family":"Leese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,6,14]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.1998.00387.x"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01658740"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01670531"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1067\/msy.2001.118377"},{"issue":"2","key":"e_1_2_8_6_2","first-page":"N68","article-title":"Clinical presentation of primary hyperparathyroidism in Europe \u2013 nationwide cohort analysis on mortality from nonmalignant causes","volume":"17","author":"Nilsson I.L.","year":"2002","journal-title":"Journal of Bone and Mineral Research"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1677\/erc.1.01261"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-003-7046-0"},{"key":"e_1_2_8_9_2","first-page":"1","article-title":"Mortality after surgery for primary hyperparathyroidism: a follow\u2010up of 441 patients operated on from 1956 to 1979","volume":"102","author":"Palmer M.","year":"1987","journal-title":"Surgery"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(87)91906-4"},{"key":"e_1_2_8_11_2","first-page":"13","article-title":"Causes of death in patients previously operated on for primary hyperparathyroidism","volume":"74","author":"Ronni\u2010Sivula H.","year":"1985","journal-title":"Annales Chirurgiae et Gynaecologiae"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002689910092"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.81.6.2036"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(97)00270-2"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6060(97)90216-6"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-1763"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-1758"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-1762"},{"key":"e_1_2_8_19_2","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1210\/jc.2008-1757","article-title":"The diagnosis and management of asymptomatic primary hyperparathyroidism revisited","volume":"94","author":"Khan A.A.","year":"2009","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-1760"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-1761"},{"key":"e_1_2_8_22_2","unstructured":"HIC. Health Informatics Centre University of Dundee.http:\/\/www.dundee.ac.uk\/hic\/."},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-1833"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-032089"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2007.03051.x"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2008.03520.x"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.328.7451.1300"},{"key":"e_1_2_8_28_2","volume-title":"Manual of the International Classification of Diseases, Injuries and Causes of Death","author":"International Classification of Diseases","year":"1977"},{"key":"e_1_2_8_29_2","volume-title":"Longitudinal Study. Mortality and Social Organisation","author":"Goldblatt P.","year":"1990"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.296.6632.1313"},{"issue":"2","key":"e_1_2_8_31_2","first-page":"S111","article-title":"Longitudinal studies of mild primary hyperparathyroidism","volume":"6","author":"Ljunghall S.","year":"1991","journal-title":"Journal of Bone and Mineral Research"},{"key":"e_1_2_8_32_2","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-08-0523"},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.4158\/EP.13.2.105"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.2009.03766.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2265.2009.03766.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T11:48:21Z","timestamp":1698752901000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.2009.03766.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,14]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["10.1111\/j.1365-2265.2009.03766.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03766.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,14]]}}}